Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Sep 18:5:23.
doi: 10.1186/1476-0711-5-23.

Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem

Asma Marzouq Al-Jasser  1
Affiliations
Case Reports

Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem

Asma Marzouq Al-Jasser. Ann Clin Microbiol Antimicrob. .

Abstract

Stenotrophomonas maltophilia (S. maltophilia) has recently emerged as an important nosocomial pathogen. Treatment of invasive infections caused by this organism is difficult as the bacterium is frequently resistant to a wide range of commonly used antimicrobials. Trimethoprim-sulfamethoxazole (TMP - SXT) is recommended as the agent of choice for the treatment of S. maltophilia infections. However, the development of resistance to this antibiotic represents a real challenge to laboratorians and clinicians. This letter describes the first isolation of S. maltophilia resistant to TMP - SXT from two patients treated at Riyadh Armed Forces Hospital which is a major tertiary hospital in Saudi Arabia.

PubMed Disclaimer

References

    1. Lennett EH, Baburs A, Hausler WJ, Shadomy HJ. Manual of Clinical Microbiology. 9. Washington DC: American Society for Microbiology;
    1. Koseoglu O, Sener B, Gulmez D, Altun B, Gur D. Stenotrophomonas maltophilia as a nosocomial pathogen. New Microbiol. 2004;27:273–279. - PubMed
    1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11:57–80. - PMC - PubMed
    1. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P. Bacteremia due to Stenotrophomonas maltophilia in patients with hematological malignancies. Clin Infect Dis. 2000;31:705–711. doi: 10.1086/314043. - DOI - PubMed
    1. Tsiodras S, Pittet D, Carmeli Y, Eliopoulos G, Boucher H, Harbath S. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis. 2000;32:651–656. doi: 10.1080/003655400459577. - DOI - PubMed

Publication types

MeSH terms